Quanyin Hu
@QuanyinHu_Lab
Followers
1K
Following
631
Media
10
Statuses
246
Joseph R. and Bonna A. Robinson Distinguished Chair, Associate Professor at UW-Madison, drug delivery, cell therapy, immunoengineering
Madison, WI
Joined March 2021
“Triple-negative breast cancer and melanoma have very high chances of coming back after surgery,” says Associate Professor Quanyin Hu. ”Our goal is to fill this unmet clinical need by preventing post-surgical recurrence.” The @dailycardinal explains how:
dailycardinal.com
Quanyin Hu, a professor in the University of Wisconsin-Madison School of Pharmacy, spoke to The Daily Cardinal about his research into personalized cancer vaccines.
0
1
3
Congrats to Quanyin Hu & Jason Peters on their promotion to associate professor! @QuanyinHu_Lab: They're creating new cell-inspired therapies for cancer & autoimmune diseases Peters Lab: They're uncovering how bacteria work to improve antibiotics & build sustainable fuels
0
1
4
Quanyin Hu's focus is on drug delivery, facilitating translational research by combining cell therapy, immunotherapy and personalized therapy. #WARF100 @uwchancellor @UWMadPharmacy
https://t.co/CPDmZzAWrm
0
1
2
Happy to be included in the WARF100 Innovators’ list! Thanks for highlighting our research and inventions! @UWMadPharmacy @WARF_News
Assistant Professor Quanyin Hu is named one of @WARF_News's 100 Innovators! His lab is improving and developing new therapies for #IBD, #cancer, and #glioblastoma to improve patient outcomes. Learn what motivates him:
0
0
10
Excited to share our new study published in PNAS! Congratulations to the team, particularly the first author graduate student Sichen Yuan https://t.co/9blHGqZwNM
pnas.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with limited treatment options due to its desmoplastic and immunosuppressive ...
0
1
11
I am extremely grateful for the strong support from the family, the past and current Hu lab members, colleagues, mentors, and friends for the past 5 years and their continued support in the future!
0
0
8
Although it is a bit late, I am excited to share with you that I was promoted to the Associate Professor with tenure and Joseph R. and Bonna A. Robinson Distinguished Chair in Pharmaceutical Sciences!@UWMadPharmacy @UWMadison
11
1
39
Researchers from @UWMadison develop personalized cancer vaccines that could help keep aggressive tumors from recurring.
wisconsin.edu
Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing personalized vaccines that could help keep aggressive tumors from recurring. Led...
0
8
27
Excited to share our new @NatureNano paper reporting new personalized cancer vaccines using pyroptotic vesicles! @UWMadPharmacy
New paper online: Engineering pyroptotic vesicles as personalized cancer vaccines. "...formed during #tumor cell pyroptosis, these vesicles serve as personalized #vaccines for post-surgical tumor recurrence inhibition." #CancerVaccine #nanotechnology
https://t.co/0SHpVklBZV
1
1
21
#awards The 2025 Journal of Nanobiotechnology (JNB) Rising Star Award is now open for nominations! Up to 4 winners will be selected this year and nominations are due 5/15/2025. Details can be found here: https://t.co/S2kWU0wbld
0
2
18
Really proud that our work published on @MedCellPress using bacteria-based delivery systems for pancreatic cancer treatment was cited by @uwchancellor as an example of “momentous year” for @UWMadison! @UWMadPharmacy
Honored to share some of @UWMadison's incredible achievements & innovations (as well as current challenges) with the @UniversitiesWI Board of Regents today, and a chance to describe plans to drive further excellence for Wisconsin and beyond. #OnWisconsin
2
1
18
A great way to warp up the year of 2024. We received the NoA of another R01 award from @theNCI on the last day of year 2024! Thanks for the support. Happy New Year! Look forward to a greater 2025. @UWMadPharmacy @UWMadison
7
1
66
Fully paper link: https://t.co/NCs5Uf6x7Y Research Briefing link: https://t.co/0B8y1kwtRV Free access link: https://t.co/ktGNyxiop5
@UWMadPharmacy @UWMadison
nature.com
Nature Biotechnology - Proteolytic chimeras constructed from various bioactive modules can degrade either cytoplasmic or extracellular proteins, but their pharmacology faces challenges. Now, a...
1
1
10
Very excited to share our latest @NatureBiotech paper: Proteolytic platelets. We grafted the proteolysis concept to chemically engineered platelets to achieve efficient degradations of both intracellular and extracellular proteins via one entity. Congratulations to the team!
13
6
94
Our lab has multiple postdoc openings. If you are interested in drug delivery, immunoengineering, and cell therapy, please consider to apply. https://t.co/sksbdOiW5Z
@UWMadPharmacy
huciptlab.net
Join us
2
17
76
Come join us! Very supportive and collaborative research environment!
If you're passionate about medicinal chemistry, drug discovery, and teaching the next generation of scientists, consider joining the School of Pharmacy as an assistant professor of pharmaceutical sciences! Find more details and apply 🔽 https://t.co/9lcLp0Fv04
0
0
4
Happy to share our @ChemSocRev collected in 2024 Emerging Investigator Issue. @UWMadPharmacy
From our 2024 #EmergingInvestigators collection "Proteolysis-targeting drug delivery system (ProDDS): integrating targeted protein degradation concepts into formulation design" by Yu Chen, Fengyuan Liu, Samira Pal and Quanyin Hu @QuanyinHu_Lab
https://t.co/BBsTpszF9g
0
1
14
Congratulations to Samira! We are proud of you.
PharmTox student Samira Pal, UW Hilldale Fellowship awardee, is working in the @QuanyinHu_Lab to create more personalized, targeted approaches to #immunotherapies for #cancer. Specifically, she's targeting ferritin, a protein that stores iron ions. https://t.co/Qn7PSeOBeH
0
0
11
🚨 In @Nature Reviews #Bioengineering, Assistant Professor Quanyin Hu (@QuanyinHu_Lab) and collaborators discuss the engineering of both mammalian and bacterial cells for disease diagnosis and therapy: https://t.co/AXG5S7mveo
#biotechnology
0
1
3